单位(元)汇添富国证生物医药ETF(159839)资产负债表 |
报告期 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
2021/12/31 |
资产 |
银行存款 |
8,052,546 |
3,293,307 |
2,883,288 |
4,596,721 |
结算备付金 |
484,790 |
436,050 |
420,874 |
576,364 |
存出保证金 |
46,160 |
48,911 |
21,717 |
37,583 |
交易性金融资产 |
684,984,011 |
451,571,581 |
338,228,455 |
338,092,021 |
其中:股票投资 |
684,984,011 |
451,571,581 |
338,228,455 |
338,092,021 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
42,003 |
- |
2,946,233 |
- |
应收利息 |
- |
- |
- |
817 |
应收股利 |
- |
- |
- |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
- |
- |
- |
资产总计 |
693,609,510 |
455,349,849 |
344,500,567 |
343,303,505 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
4,658,347 |
556,503 |
3,957,919 |
1,248,619 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
278,740 |
194,875 |
130,724 |
141,279 |
应付托管费 |
55,748 |
38,975 |
26,145 |
28,256 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
154,157 |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
366,022 |
357,157 |
356,697 |
150,000 |
负债合计 |
5,358,858 |
1,147,510 |
4,471,485 |
1,722,310 |
所有者权益 |
实收基金 |
1,568,235,165 |
809,235,165 |
504,735,165 |
436,735,165 |
未分配利润 |
-879,984,512 |
-355,032,826 |
-164,706,083 |
-95,153,970 |
所有者权益合计 |
688,250,653 |
454,202,339 |
340,029,082 |
341,581,195 |
负债和所有者权益总计 |
693,609,510 |
455,349,849 |
344,500,567 |
343,303,505 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。